Exchange: NASDAQ·Updated 04:00 PM EDT
ANIX logo

ANIX Anixa Biosciences Inc

$2.80
$0.04
(1.45%)
Today
EarningsJan 12
Mkt Cap$95.95M
Vol376,445.00

About ANIX

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The Other segment refers to its legacy operations, including patent licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
55

Bullish Sentiment

How do you feel about ANIX?

Advertisement|Remove ads.